{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:51:04Z","timestamp":1792612264982,"version":"4.5.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T00:00:00Z","timestamp":1735862400000},"content-version":"vor","delay-in-days":368,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.ymthe.2023.11.003","type":"journal-article","created":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T13:10:54Z","timestamp":1699103454000},"page":"241-256","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Oncolytic \u03b1-herpesvirus and myeloid-tropic cytomegalovirus cooperatively enhance systemic antitumor responses"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6451-4236","authenticated-orcid":false,"given":"Haifei","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Nace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Ariail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yejun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"McGlinch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coryn","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talia","family":"Fernandez Carrasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandakumar","family":"Packiriswamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kah Whye","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2023.11.003_bib1","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1001\/jamaoncol.2016.2064","article-title":"Oncolytic Viruses in Cancer Treatment: A Review","volume":"3","author":"Lawler","year":"2017","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.ymthe.2023.11.003_bib2","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ccell.2018.03.011","article-title":"Oncolytic Viruses as Antigen-Agnostic Cancer Vaccines","volume":"33","author":"Russell","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ymthe.2023.11.003_bib3","doi-asserted-by":"crossref","first-page":"e001486","DOI":"10.1136\/jitc-2020-001486","article-title":"Clinical landscape of oncolytic virus research in 2020","volume":"8","author":"Macedo","year":"2020","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.ymthe.2023.11.003_bib4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s43856-022-00098-4","article-title":"Advances in oncolytic virotherapy","volume":"2","author":"Russell","year":"2022","journal-title":"Commun. Med."},{"key":"10.1016\/j.ymthe.2023.11.003_bib5","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3389\/fonc.2020.00188","article-title":"Tumor-Associated Macrophages: Recent Insights and Therapies","volume":"10","author":"Zhou","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ymthe.2023.11.003_bib6","first-page":"41","article-title":"Alphaherpesvirus Genomics: Past, Present and Future","volume":"42","author":"Kuny","year":"2021","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.ymthe.2023.11.003_bib7","doi-asserted-by":"crossref","first-page":"15010-","DOI":"10.1038\/mto.2015.10","article-title":"Designing Herpes Viruses as Oncolytics","volume":"2","author":"Peters","year":"2015","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.ymthe.2023.11.003_bib8","doi-asserted-by":"crossref","first-page":"e1000971","DOI":"10.1371\/journal.ppat.1000971","article-title":"Genome-wide mutagenesis reveals that ORF7 is a novel VZV skin-tropic factor","volume":"6","author":"Zhang","year":"2010","journal-title":"Plos Pathog."},{"key":"10.1016\/j.ymthe.2023.11.003_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/v12121354","article-title":"Evasion of the Cell-Mediated Immune Response by Alphaherpesviruses","volume":"12","author":"Koyanagi","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.ymthe.2023.11.003_bib10","doi-asserted-by":"crossref","first-page":"979","DOI":"10.3390\/v1030979","article-title":"Innate and adaptive immune responses to herpes simplex virus","volume":"1","author":"Chew","year":"2009","journal-title":"Viruses"},{"key":"10.1016\/j.ymthe.2023.11.003_bib11","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.tim.2016.11.009","article-title":"Herpesviruses and Their Host Cells: A Successful Liaison","volume":"25","author":"Adler","year":"2017","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.ymthe.2023.11.003_bib12","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.3389\/fimmu.2019.01155","article-title":"Subversion of Immune Response by Human Cytomegalovirus","volume":"10","author":"Patro","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2023.11.003_bib13","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00430-015-0403-4","article-title":"Cytomegalovirus immune evasion of myeloid lineage cells","volume":"204","author":"Brinkmann","year":"2015","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.ymthe.2023.11.003_bib14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1128\/JVI.01585-12","article-title":"Human cytomegalovirus infection of M1 and M2 macrophages triggers inflammation and autologous T-cell proliferation","volume":"87","author":"Bayer","year":"2013","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2023.11.003_bib15","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00430-019-00610-z","article-title":"Adverse immunological imprinting by cytomegalovirus sensitizing for allergic airway disease","volume":"208","author":"Reddehase","year":"2019","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.ymthe.2023.11.003_bib16","doi-asserted-by":"crossref","first-page":"10095","DOI":"10.1073\/pnas.0804551105","article-title":"Structure of UL18, a peptide-binding viral MHC mimic, bound to a host inhibitory receptor","volume":"105","author":"Yang","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2023.11.003_bib17","doi-asserted-by":"crossref","first-page":"eabe9233","DOI":"10.1126\/science.abe9233","article-title":"Modulation of MHC-E transport by viral decoy ligands is required for RhCMV\/SIV vaccine efficacy","volume":"372","author":"Verweij","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2023.11.003_bib18","doi-asserted-by":"crossref","first-page":"10896","DOI":"10.1073\/pnas.1834449100","article-title":"HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+ cytolytic T lymphocytes","volume":"100","author":"Pietra","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2023.11.003_bib19","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.coi.2017.06.010","article-title":"CD8+ T\u00a0cell programming by cytomegalovirus vectors: applications in prophylactic and therapeutic vaccination","volume":"47","author":"Fr\u00fch","year":"2017","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.ymthe.2023.11.003_bib20","doi-asserted-by":"crossref","first-page":"285ra63","DOI":"10.1126\/scitranslmed.aaa2546","article-title":"CMV-specific T\u00a0cells generated from naive T\u00a0cells recognize atypical epitopes and may be protective in\u00a0vivo","volume":"7","author":"Hanley","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2023.11.003_bib21","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13567-015-0228-6","article-title":"Comparison of the pathogenesis of the highly passaged MCMV Smith strain with that of the low passaged MCMV HaNa1 isolate in BALB\/c mice upon oronasal inoculation","volume":"46","author":"Zhang","year":"2015","journal-title":"Vet. Res."},{"key":"10.1016\/j.ymthe.2023.11.003_bib22","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1084\/jem.194.7.967","article-title":"The multiple immune-evasion genes of murine cytomegalovirus are not redundant: m4 and m152 inhibit antigen presentation in a complementary and cooperative fashion","volume":"194","author":"Kavanagh","year":"2001","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ymthe.2023.11.003_bib23","doi-asserted-by":"crossref","first-page":"28857","DOI":"10.1074\/jbc.M115.689661","article-title":"A Novel MHC-I Surface Targeted for Binding by the MCMV m06 Immunoevasin Revealed by Solution NMR","volume":"290","author":"Sgourakis","year":"2015","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2023.11.003_bib24","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1084\/jem.190.3.435","article-title":"m144, a murine cytomegalovirus (MCMV)-encoded major histocompatibility complex class I homologue, confers tumor resistance to natural killer cell-mediated rejection","volume":"190","author":"Cretney","year":"1999","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ymthe.2023.11.003_bib25","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00430-022-00733-w","article-title":"Cytomegalovirus immune evasion sets the functional avidity threshold for protection by CD8 T\u00a0cells","volume":"212","author":"Hamdan","year":"2023","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.ymthe.2023.11.003_bib26","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.celrep.2019.03.059","article-title":"Qa-1-Restricted CD8(+) T Cells Can Compensate for the Absence of Conventional T Cells during Viral Infection","volume":"27","author":"Anderson","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2023.11.003_bib27","doi-asserted-by":"crossref","first-page":"112317","DOI":"10.1016\/j.celrep.2023.112317","article-title":"Murine cytomegalovirus downregulates ERAAP and induces an unconventional T\u00a0cell response to self","volume":"42","author":"Geiger","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2023.11.003_bib28","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1038\/mt.2016.121","article-title":"Intratumoral Infection with Murine Cytomegalovirus Synergizes with PD-L1 Blockade to Clear Melanoma Lesions and Induce Long-term Immunity","volume":"24","author":"Erkes","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2023.11.003_bib29","doi-asserted-by":"crossref","first-page":"e01264-17","DOI":"10.1128\/mBio.01264-17","article-title":"Murine Cytomegalovirus Spreads by Dendritic Cell Recirculation","volume":"8","author":"Farrell","year":"2017","journal-title":"mBio"},{"key":"10.1016\/j.ymthe.2023.11.003_bib30","doi-asserted-by":"crossref","first-page":"7147","DOI":"10.1128\/JVI.00480-15","article-title":"Lymph Node Macrophages Restrict Murine Cytomegalovirus Dissemination","volume":"89","author":"Farrell","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2023.11.003_bib31","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3389\/fimmu.2017.00105","article-title":"gammadelta T Cell-Mediated Immunity to Cytomegalovirus Infection","volume":"8","author":"Khairallah","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2023.11.003_bib32","doi-asserted-by":"crossref","first-page":"e1006057","DOI":"10.1371\/journal.ppat.1006057","article-title":"The Mouse Cytomegalovirus Gene m42 Targets Surface Expression of the Protein Tyrosine Phosphatase CD45 in Infected Macrophages","volume":"12","author":"Thiel","year":"2016","journal-title":"Plos Pathog."},{"key":"10.1016\/j.ymthe.2023.11.003_bib33","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.micinf.2004.05.020","article-title":"Murine cytomegalovirus infection directs macrophage differentiation into a pro-inflammatory immune phenotype: implications for atherogenesis","volume":"6","author":"Vliegen","year":"2004","journal-title":"Microbes Infect."},{"key":"10.1016\/j.ymthe.2023.11.003_bib34","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1172\/JCI83987","article-title":"T regulatory cell chemokine production mediates pathogenic T\u00a0cell attraction and suppression","volume":"126","author":"Patterson","year":"2016","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2023.11.003_bib35","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1742-2094-9-93","article-title":"CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation","volume":"9","author":"Kowarik","year":"2012","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.ymthe.2023.11.003_bib36","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13046-015-0278-7","article-title":"Anti-tumor effects of pigment epithelium-derived factor (PEDF): implication for cancer therapy. A mini-review","volume":"35","author":"Belkacemi","year":"2016","journal-title":"J.\u00a0Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ymthe.2023.11.003_bib37","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3390\/v11020168","article-title":"Myeloid Cells during Viral Infections and Inflammation","volume":"11","author":"Stegelmeier","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.ymthe.2023.11.003_bib38","doi-asserted-by":"crossref","first-page":"899","DOI":"10.3389\/fonc.2020.00899","article-title":"The Role of Tumor-Associated Myeloid Cells in Modulating Cancer Therapy","volume":"10","author":"Neophytou","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ymthe.2023.11.003_bib39","doi-asserted-by":"crossref","first-page":"e1010435","DOI":"10.1371\/journal.ppat.1010435","article-title":"A surface pocket in the cytoplasmic domain of the herpes simplex virus fusogen gB controls membrane fusion","volume":"18","author":"Pataki","year":"2022","journal-title":"Plos Pathog."},{"key":"10.1016\/j.ymthe.2023.11.003_bib40","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12979-017-0093-4","article-title":"Herpes virus seroepidemiology in the adult Swedish population","volume":"14","author":"Olsson","year":"2017","journal-title":"Immun. Ageing."},{"key":"10.1016\/j.ymthe.2023.11.003_bib41","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/mi.2014.42","article-title":"Mck2-dependent infection of alveolar macrophages promotes replication of MCMV in nodular inflammatory foci of the neonatal lung","volume":"8","author":"Stahl","year":"2015","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.ymthe.2023.11.003_bib42","doi-asserted-by":"crossref","first-page":"e1003493","DOI":"10.1371\/journal.ppat.1003493","article-title":"The viral chemokine MCK-2 of murine cytomegalovirus promotes infection as part of a gH\/gL\/MCK-2 complex","volume":"9","author":"Wagner","year":"2013","journal-title":"Plos Pathog."},{"key":"10.1016\/j.ymthe.2023.11.003_bib43","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.molimm.2009.02.010","article-title":"Promiscuity of MCMV immunoevasin of NKG2D: m138\/fcr-1 down-modulates RAE-1epsilon in addition to MULT-1 and H60","volume":"47","author":"Arapovi\u0107","year":"2009","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.ymthe.2023.11.003_bib44","doi-asserted-by":"crossref","first-page":"13062","DOI":"10.1128\/JVI.78.23.13062-13071.2004","article-title":"Identification of a mouse cytomegalovirus gene selectively targeting CD86 expression on antigen-presenting cells","volume":"78","author":"Loewendorf","year":"2004","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2023.11.003_bib45","doi-asserted-by":"crossref","first-page":"e01220-19","DOI":"10.1128\/JVI.01220-19","article-title":"Mouse Cytomegalovirus m153 Protein Stabilizes Expression of the Inhibitory NKR-P1B Ligand Clr-b","volume":"94","author":"Aguilar","year":"2019","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2023.11.003_bib46","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jmb.2006.01.068","article-title":"Crystal structure of the murine cytomegalovirus MHC-I homolog m144","volume":"358","author":"Natarajan","year":"2006","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.ymthe.2023.11.003_bib47","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1245\/s10434-019-07691-3","article-title":"Efficacy of Talimogene Laherparepvec (T-VEC) Therapy in Patients with In-Transit Melanoma Metastasis Decreases with Increasing Lesion Size","volume":"26","author":"Masoud","year":"2019","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ymthe.2023.11.003_bib48","doi-asserted-by":"crossref","first-page":"834841","DOI":"10.3389\/fmolb.2022.834841","article-title":"Talimogene Laherparepvec: Moving From First-In-Class to Best-In-Class","volume":"9","author":"Kaufman","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.ymthe.2023.11.003_bib49","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.coviro.2016.07.007","article-title":"Oncolytic herpes simplex virus interactions with the host immune system","volume":"21","author":"Saha","year":"2016","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.ymthe.2023.11.003_bib50","doi-asserted-by":"crossref","first-page":"e1006905","DOI":"10.1371\/journal.ppat.1006905","article-title":"Murine cytomegalovirus degrades MHC class II to colonize the salivary glands","volume":"14","author":"Yunis","year":"2018","journal-title":"Plos Pathog."},{"key":"10.1016\/j.ymthe.2023.11.003_bib51","doi-asserted-by":"crossref","first-page":"636568","DOI":"10.3389\/fimmu.2021.636568","article-title":"Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation","volume":"12","author":"Dhatchinamoorthy","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2023.11.003_bib52","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3389\/fimmu.2015.00298","article-title":"Alternative Antigen Processing for MHC Class I: Multiple Roads Lead to Rome","volume":"6","author":"Oliveira","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2023.11.003_bib53","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.3390\/cancers12071760","article-title":"MHC Class I Downregulation in Cancer: Underlying Mechanisms and Potential Targets for Cancer Immunotherapy","volume":"12","author":"Cornel","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ymthe.2023.11.003_bib54","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3389\/fcimb.2020.00454","article-title":"Positive Role of the MHC Class-I Antigen Presentation Regulator m04\/gp34 of Murine Cytomegalovirus in Antiviral Protection by CD8\u00a0T Cells","volume":"10","author":"Becker","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ymthe.2023.11.003_bib55","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s40425-019-0682-1","article-title":"Development of a new fusion-enhanced oncolytic immunotherapy platform based on herpes simplex virus type 1","volume":"7","author":"Thomas","year":"2019","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.ymthe.2023.11.003_bib56","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.2217\/fon-2022-0440","article-title":"Oncolytic viruses: challenges and considerations in an evolving clinical landscape","volume":"18","author":"Lauer","year":"2022","journal-title":"Future Oncol."},{"key":"10.1016\/j.ymthe.2023.11.003_bib57","first-page":"Unit14E.4","article-title":"Human cytomegalovirus: bacterial artificial chromosome (BAC) cloning and genetic manipulation","volume":"Chapter 14","author":"Paredes","year":"2012","journal-title":"Curr. Protoc. Microbiol."},{"key":"10.1016\/j.ymthe.2023.11.003_bib58","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/cgt.2013.43","article-title":"HSV-NIS, an oncolytic herpes simplex virus type 1 encoding human sodium iodide symporter for preclinical prostate cancer radiovirotherapy","volume":"20","author":"Li","year":"2013","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.ymthe.2023.11.003_bib59","doi-asserted-by":"crossref","first-page":"e1193","DOI":"10.21769\/BioProtoc.1193","article-title":"Purification of Herpesvirus Virions and Capsids","volume":"4","author":"Dai","year":"2014","journal-title":"Bio. Protoc."},{"key":"10.1016\/j.ymthe.2023.11.003_bib60","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1479-5876-2-9","article-title":"A modified human ELISPOT assay to detect specific responses to primary tumor cell targets","volume":"2","author":"Malyguine","year":"2004","journal-title":"J.\u00a0Transl. Med."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001623006056?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001623006056?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T20:34:12Z","timestamp":1736282052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001623006056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S1525001623006056"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2023.11.003","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2817662\/v1","asserted-by":"object"}]},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oncolytic \u03b1-herpesvirus and myeloid-tropic cytomegalovirus cooperatively enhance systemic antitumor responses","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2023.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}